Sanara MedTech Inc. (SMTI)
SMTI Stock Price Chart
Explore Sanara MedTech Inc. interactive price chart. Choose custom timeframes to analyze SMTI price movements and trends.
SMTI Company Profile
Discover essential business fundamentals and corporate details for Sanara MedTech Inc. (SMTI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
7 Apr 1994
Employees
141.00
Website
https://sanaramedtech.comCEO
Ronald T. Nixon
Description
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako's Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
SMTI Financial Timeline
Browse a chronological timeline of Sanara MedTech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.24, while revenue estimate is $26.63M.
Earnings released on 13 Aug 2025
EPS came in at -$0.23 surpassing the estimated -$0.33 by +30.30%, while revenue for the quarter reached $25.83M , missing expectations by -2.89%.
Earnings released on 14 May 2025
EPS came in at -$0.41 falling short of the estimated -$0.31 by -32.26%, while revenue for the quarter reached $23.43M , missing expectations by -5.89%.
Earnings released on 25 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%, while revenue for the quarter reached $26.31M , beating expectations by +9.15%.
Earnings released on 12 Nov 2024
EPS came in at -$0.34 surpassing the estimated -$0.62 by +45.16%, while revenue for the quarter reached $21.67M , missing expectations by -3.25%.
Earnings released on 12 Aug 2024
EPS came in at -$0.41 falling short of the estimated -$0.21 by -95.24%, while revenue for the quarter reached $20.16M , beating expectations by +5.54%.
Earnings released on 13 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.07 by -200.00%, while revenue for the quarter reached $18.54M , beating expectations by +0.20%.
Earnings released on 25 Mar 2024
EPS came in at -$0.03 surpassing the estimated -$0.13 by +76.92%, while revenue for the quarter reached $17.69M , beating expectations by +7.21%.
Earnings released on 13 Nov 2023
EPS came in at -$0.13 matching the estimated -$0.13, while revenue for the quarter reached $16.02M , missing expectations by -2.88%.
Earnings released on 14 Aug 2023
EPS came in at -$0.22 falling short of the estimated -$0.13 by -69.23%, while revenue for the quarter reached $15.75M , missing expectations by -6.79%.
Earnings released on 15 May 2023
EPS came in at -$0.20 surpassing the estimated -$0.33 by +39.39%, while revenue for the quarter reached $15.52M , missing expectations by -9.76%.
Earnings released on 20 Mar 2023
EPS came in at -$0.51 falling short of the estimated -$0.26 by -96.15%, while revenue for the quarter reached $15.32M , beating expectations by +3.49%.
Earnings released on 14 Nov 2022
EPS came in at -$0.18 surpassing the estimated -$0.32 by +43.75%, while revenue for the quarter reached $13.04M , missing expectations by -11.26%.
Earnings released on 15 Aug 2022
EPS came in at -$0.42 falling short of the estimated -$0.28 by -50.00%, while revenue for the quarter reached $9.67M , beating expectations by +11.16%.
Earnings released on 16 May 2022
EPS came in at -$0.41 , while revenue for the quarter reached $7.81M , beating expectations by 0.00%.
Earnings released on 30 Mar 2022
EPS came in at -$0.48 falling short of the estimated -$0.27 by -77.78%, while revenue for the quarter reached $7.03M , beating expectations by +15.30%.
Earnings released on 12 Nov 2021
EPS came in at -$0.27 falling short of the estimated -$0.18 by -50.00%, while revenue for the quarter reached $5.82M .
Earnings released on 16 Aug 2021
EPS came in at -$0.16 , while revenue for the quarter reached $6.28M , missing expectations by -74.06%.
Earnings released on 17 May 2021
EPS came in at -$0.17 , while revenue for the quarter reached $5.01M .
Earnings released on 30 Mar 2021
EPS came in at -$0.04 , while revenue for the quarter reached $4.79M .
Earnings released on 13 Nov 2020
EPS came in at -$0.18 , while revenue for the quarter reached $4.31M .
SMTI Stock Performance
Access detailed SMTI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.